Skip to main content

Table 1 Clinical characteristics. of liver organ donors (top) and liver transplant recipients (bottom) of 122 single center liver transplantations (LTs)

From: Visual quality assessment of the liver graft by the transplanting surgeon predicts postreperfusion syndrome after liver transplantation: a retrospective cohort study

 

All LTs (n = 122)

PRS (n = 65)

no PRS (n = 57)

P

Donor characteristics

Age [years]

55.2 ± 16.2

57.1 ± 15.1

53.1 ± 17.2

0.18

Sex [female]

57 (46.7%)

32 (49.2%)

24 (42.1%)

0.42

BMI [kg/cm2]

28.8 ± 7.2

31.1 ± 8.2

26.4 ± 4.8

< 0.001

Sodium [mmol/L]

147.7 ± 8.2

149.1 ± 7.8

146.1 ± 8.4

0.04

ALT [U/L]

114.2 ± 289.6

106.7 ± 223.2

122.8 ± 352.4

0.77

AST [U/L]

124.4 ± 237.8

115.9 ± 182.1

134.1 ± 290.0

0.69

Bilirubine [mg/dL]

0.86 ± 1.23

0.80 ± 1.33

0.93 ± 1.13

0.59

Cold ischemic time [h]

8.3 ± 2.3

8.7 ± 2.3

7.8 ± 2.3

0.04

  ≥ 10 h [n]

23 (18.9%)

17 (26.2%)

6 (10.5%)

0.02

Warm ischemic time [min]

43.7 ± 7.5

44.9 ± 6.7

42.3 ± 8.2

0.06

Recipient characteristics

Age [years]

54.9 ± 9.8

55.2 ± 9.8

54.5 ± 9.8

0.69

Sex [female]

43 (35.2%)

21 (32.3%)

22 (38.6%)

0.57

BMI [kg/cm2]

27.6 ± 5.3

27.3 ± 5.5

28.1 ± 5.0

0.41

Diagnosis [n]

 acute liver failure

12 (9.8%)

10 (15.4%)

2 (3.5%)

0.03

 acute on chronic

5 (4.1%)

1 (1.5%)

4 (7.0%)

0.18

 cirrhosis

57 (46.7%)

20 (30.8%)

37 (64.9%)

< 0.001

 tumor

25 (20.5%)

14 (21.5%)

11 (19.3%)

0.82

 graft failure

7 (5.7%)

2 (3.1%)

5 (8.8%)

0.25

 others (PSC, polycystic)

16 (13.1%)

10 (15.4%)

6 (10.5%)

0.59

portal hypertension

85 (69.7%)

52 (80.0%)

33 (57.9%)

0.01

labMELD

19.8 ± 10.3

20.0 ± 9.9

19.6 ± 10.8

0.82

Creatinine preop [mg/dl]

1.71 ± 1.49

1.75 ± 0.23

1.66 ± 0.15

0.14

preoperative RRT [n]

15 (12.3%)

8 (12.3%)

7 (12.3%)

1.00

  1. LT Liver transplantation, PRS postreperfusion syndrome, BMI body mass index, ALT Alanine transferase, AST Aspartat transferase, labMELD laboratory Model of end-stage liver disease score, RRT renal replacement therapy
  2. Clinical characteristics of liver organ donors (top) and liver transplant recipients (bottom) of 122 single center LTs. The characteristics are displayed for the whole study population (left) and by occurrence of postoperative reperfusion syndrome; mean and standard deviation (SD) or frequencies